Achillion (ACHN) Higher on Further HCV Development, Inhibitex Buyout; Up ~10%
Go back to Achillion (ACHN) Higher on Further HCV Development, Inhibitex Buyout; Up ~10%| Achillion Pharmaceuticals, Inc. (AMEX: ACHN) | Delayed: 0.79 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.79 | 52 Week High | $10.95 | |||
| Open | $15.10 | 52 Week Low | $3.78 | |||
| Day High | $0.79 | P/E | N/A | |||
| Day Low | $0.79 | EPS | $-0.63 | |||
| Volume | 504,330 | |||||
| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 66.58 -0.37 (0.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.95 | 52 Week High | $77.12 | |||
| Open | $66.77 | 52 Week Low | $49.03 | |||
| Day High | $66.84 | P/E | 43.23 | |||
| Day Low | $66.19 | EPS | $1.54 | |||
| Volume | 5,543,469 | |||||
| Inhibitex, Inc. (NASDAQ: INHX) | Delayed: 26.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.00 | 52 Week High | $26.01 | |||
| Open | $1.33 | 52 Week Low | $2.15 | |||
| Day High | $26.00 | P/E | N/A | |||
| Day Low | $26.00 | EPS | $-0.38 | |||
| Volume | 470,537 | |||||
